amlodipine and benazepril hydrochloride
Generic: amlodipine and benazepril hydrochloride
Labeler: avkareDrug Facts
Product Profile
Brand Name
amlodipine and benazepril hydrochloride
Generic Name
amlodipine and benazepril hydrochloride
Labeler
avkare
Dosage Form
CAPSULE
Routes
Active Ingredients
amlodipine besylate 5 mg/1, benazepril hydrochloride 10 mg/1
Manufacturer
Identifiers & Regulatory
Product NDC
42291-011
Product ID
42291-011_3c1cb59c-965a-92df-e063-6394a90a7b0a
Product Type
HUMAN PRESCRIPTION DRUG
Marketing Category
ANDA
Application Number
ANDA202239
Listing Expiration
2026-12-31
Marketing Start
2023-06-20
Pharmacologic Class
Classes
Normalized Code Variants
Searchable formats for this product NDC code
Digits Only
42291011
Hyphenated Format
42291-011
Supplemental Identifiers
RxCUI
UPC
UNII
Resolved Product View
Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.
Resolved Identity
Brand Name
amlodipine and benazepril hydrochloride (source: ndc)
Generic Name
amlodipine and benazepril hydrochloride (source: ndc)
Application Number
ANDA202239 (source: ndc)
Routes
source: ndc
Resolved Composition
Strengths
- 5 mg/1
- 10 mg/1
Packaging
- 100 CAPSULE in 1 BOTTLE (42291-011-01)
Packages (1)
Ingredients (2)
Linked Drug Pages (1)
Raw FDA Data
View complete raw FDA NDC JSON payload
{"route": ["ORAL"], "spl_id": "3c1cb59c-965a-92df-e063-6394a90a7b0a", "openfda": {"upc": ["0041000006883"], "unii": ["864V2Q084H", "N1SN99T69T"], "rxcui": ["898342", "898346", "898353", "898356", "898359"], "spl_set_id": ["fe91d607-5e1f-48e4-e053-6294a90ac522"], "manufacturer_name": ["AvKARE"]}, "finished": true, "packaging": [{"sample": false, "description": "100 CAPSULE in 1 BOTTLE (42291-011-01)", "package_ndc": "42291-011-01", "marketing_start_date": "20230620"}], "brand_name": "Amlodipine and Benazepril Hydrochloride", "product_id": "42291-011_3c1cb59c-965a-92df-e063-6394a90a7b0a", "dosage_form": "CAPSULE", "pharm_class": ["Angiotensin Converting Enzyme Inhibitor [EPC]", "Angiotensin-converting Enzyme Inhibitors [MoA]", "Calcium Channel Antagonists [MoA]", "Calcium Channel Blocker [EPC]", "Cytochrome P450 3A Inhibitors [MoA]", "Decreased Blood Pressure [PE]", "Dihydropyridine Calcium Channel Blocker [EPC]", "Dihydropyridines [CS]"], "product_ndc": "42291-011", "generic_name": "Amlodipine and Benazepril Hydrochloride", "labeler_name": "AvKARE", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Amlodipine and Benazepril Hydrochloride", "active_ingredients": [{"name": "AMLODIPINE BESYLATE", "strength": "5 mg/1"}, {"name": "BENAZEPRIL HYDROCHLORIDE", "strength": "10 mg/1"}], "application_number": "ANDA202239", "marketing_category": "ANDA", "marketing_start_date": "20230620", "listing_expiration_date": "20261231"}